Subscribe
San Francisco, CA —Radiation added to hormone therapy with antiandrogens extended cancer-specific survival, as well as overall survival, when used as the primary treatment of patients with locally advanced or high-risk prostate cancer. In the Scandinavian Prostate Cancer Group VII study, 10- and 15-year survival improved by more than 50% in patients who received radiation plus hormone therapy versus hormone therapy alone, according to an updated analysis presented at the 2014 ASCO Genitourinary Cancers Symposium.
San Diego, CA—Do you know where your practice is heading? If so, you are in control of your practice’s destiny. Dennis Wipperling, FACMPE, practice administrator with Surgical Specialists of Minnesota, Minneapolis, spoke at the Medical Group Management Association’s annual conference, where he noted that planning today is not what it used to be. Whereas organizations once had 5-year plans, these plans are much shorter now, necessitated by the many changes coming from Washington, DC.
Practicing medicine is no longer exclusively characterized as providing patient care. A physician is now required to be a skilled clinician, a marketing guru, an entrepreneur, an accountant, and a legal savant, given the level of financial hurdles and oversight that is required to run a successful practice today.
San Francisco, CA—Enzalutamide (Xtandi) prolonged survival and delayed radiographic progression of disease in men who had not received chemotherapy for metastatic castration-resistant prostate cancer (mCRPC). The complete results of the phase 3 PREVAIL trial were presented at the 2014 Genitourinary Cancers Symposium.
San Francisco, CA—Researchers have successfully completed a comprehensive characterization of molecular alterations in muscle-invasive urothelial bladder carcinoma as part of The Cancer Genome Atlas (TCGA) project.
San Francisco, CA—Penile cancer is not very common in the United States, but it can be potentially fatal and appropriate treatment is crucial. A new, large population-based study showed that the management of patients with penile cancer in the United States is often not in line with current guidelines, including the 2013 National Comprehensive Cancer Network (NCCN) clinical guidelines for the management of penile cancer.
San Diego, CA—Randy W. Cook, MPH, FACMPE, president and CEO of AmpliPHY Physician Services, Columbia, TN, offered some hope to listeners at the Medical Group Management Association’s annual conference. His message: “You have more leverage than any health plan will tell you about.”
All urology practices are facing serious changes brought about by government and healthcare reform, some of which have not been fleshed out clearly enough. In the midst of this flux, practice managers must assess their practice’s performance and needs and make decisions that will affect the continued health and financial success of their business operations.

Results 1 - 8 of 8
  • American Health and Drug Benefits
  • Association for Value Based Cancer Care
  • Lynx CME
  • Oncology Practice Management
  • Rheumatology Practice Management

Search